Back to Clinical Trials
N/ARecruiting

Home Tele Rehabilitation Therapy for Vascular Dementia

Sponsored by The Methodist Hospital Research Institute

About this study

To determine whether the home telerehabilitation therapy is feasible and lessens caregiver burden in chronic stroke patients with and without vascular dementia (VaD)

This is a controlled evaluator masked parallel study of chronic (\>6mo from stroke onset) ischemic or hemorrhagic stroke patients diagnosed with and without vascular dementia to test the feasibility and effect of remote rehabilitation therapy targeting the weaker arm compared to usual care. All patients will undergo baseline evaluation, then usual care for 1 month followed by a remote telerehabilitation treatment for one month, followed by an evaluation 1 month after the completion of treatment. Research procedures: Subject Recruitment/Screening: Participants will be recruited from the PI's stroke recovery specialty clinic, and the Houston Methodist Hospital system by flyers and educating clinicians about the proposed study and the patient requirements. Prospective participants may also …

Where this study is enrolling

Who can participate

Inclusion criteria

  • ✓Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging
  • ✓at least 6 months post stroke
  • ✓At least some active movement in the affected upper extremity (MRS 1 or more in shoulder elbow or wrist)
  • ✓Ability to provide informed consent, or LAR able to provide consent
  • ✓Expressed willingness to comply with all study procedures and attend all study-related visits for both the patient and at least one caregiver.
  • ✓Age ≥ 18.
  • ✓Ability to follow one-step commands.
  • ✓Community-dwelling with transportation to evaluation sessions.
  • ✓Ability to operate the therapy system with minimal assistance, including sufficient corrected vision to perceive objects from a distance of 5 feet.
  • ✓Modified Ashworth Scale Score 3 or less in the involved upper extremity
  • ✓Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand

Exclusion criteria

  • ✕Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as unable to follow study instructions even with help from caregiver).
  • ✕Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.)
  • ✕Patients with severe uncontrolled medical problems that would render intensive rehabilitation unfeasible or unsafe (e.g. cardiovascular disease, unstable cardiac arrhythmia, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age, epilepsy or others).
  • ✕Concurrent participation in other experimental upper extremity rehabilitation trials that would interfere with results.
  • ✕Non-English-speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services. However, we plan to include them once funding has been secured in the subsequent larger trial.
  • ✕Pregnancy
  • ✕Prisoners

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.